Biomarkers in high grade serous ovarian cancer

M Bates, BM Mohamed, F Lewis, S O'Toole… - … et Biophysica Acta (BBA …, 2024 - Elsevier
High-grade serous ovarian cancer (HGSC) is the most common subtype of ovarian cancer.
HGSC patients typically present with advanced disease, which is often resistant to …

Advances on Senescence-associated Secretory Phenotype Regulated by Circular RNAs in Tumors

Y Qiu, S Zhang, C Man, D Gong, Y Xu, X Wang… - Ageing Research …, 2024 - Elsevier
The components that comprise the senescence-associated secretory phenotype (SASP)
include growth factors, proteases, chemokines, cytokines, and bioactive lipids. It drives …

[HTML][HTML] Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances

ZX Chong, WY Ho, SK Yeap - Non-coding RNA Research, 2024 - Elsevier
Liposarcoma is one of the most prevalent forms of soft tissue sarcoma, and its prognosis is
highly dependent on its molecular subtypes. Non-coding RNAs (ncRNAs) like microRNAs …

The Role of the Plasminogen Activator Inhibitor 1 (PAI1) in Ovarian Cancer: Mechanisms and Therapeutic Implications

SG Mathews, RBD Krishna, M Lavanya… - Global Medical …, 2024 - thieme-connect.com
Ovarian cancer (OC) is one among most significantly fatal gynecological cancers, with late-
stage detection and an inadequate prognosis. Plasminogen activator inhibitor-1 (PAI1) gene …